Assignee
SLAYBACK PHARMA LLC
US·42 granted patents·27 pending applications·71 citations·filing 2018–2025
Top patents by PatentIndex Score
69 records- 0197US10874671B2Pharmaceutical compositions of nilotinibSLAYBACK PHARMA LLC·Filed 2020·Granted Dec 29, 2020·17 cites·23 claims
- 0296US11679105B1Pharmaceutical compositions of cabozantinibSLAYBACK PHARMA LLC·Filed 2023·Granted Jun 20, 2023·11 cites·13 claims
- 0396US11590122B2Pharmaceutical compositions of cabozantinibSLAYBACK PHARMA LLC·Filed 2022·Granted Feb 28, 2023·14 cites·12 claims
- 0493US12138255B2Pharmaceutical compositions of cabozantinibSLAYBACK PHARMA LLC·Filed 2023·Granted Nov 12, 2024·2 cites·6 claims
- 0593US11707450B1Stable pharmaceutical compositions of bendamustineSLAYBACK PHARMA LLC·Filed 2022·Granted Jul 25, 2023·5 cites·10 claims
- 0693US11484518B1Stable oral suspensions of baclofenSLAYBACK PHARMA LLC·Filed 2022·Granted Nov 1, 2022·2 cites·17 claims
- 0792US11878025B2Pharmaceutical compositions of mifepristoneSLAYBACK PHARMA LLC·Filed 2022·Granted Jan 23, 2024·4 cites·29 claims
- 0892US11793809B2Pharmaceutical compositions of nilotinibSLAYBACK PHARMA LLC·Filed 2020·Granted Oct 24, 2023·2 cites·9 claims
- 0990US12233049B2Stable pharmaceutical compositions of clonidineSLAYBACK PHARMA LLC·Filed 2022·Granted Feb 25, 2025·4 cites·23 claims
- 1090US12213972B2Stable pharmaceutical compositions of apixabanSLAYBACK PHARMA LLC·Filed 2024·Granted Feb 4, 2025·2 cites·18 claims
- 1189US12440474B2Stable pharmaceutical compositions of clonidineSLAYBACK PHARMA LLC·Filed 2025·Granted Oct 14, 2025·1 cites·19 claims
- 1289US12263176B2Pharmaceutical liquid compositions of meloxicamSLAYBACK PHARMA LLC·Filed 2023·Granted Apr 1, 2025·1 cites·14 claims
- 1389US11872305B2Stable pharmaceutical compositions of succinylcholine chlorideSLAYBACK PHARMA LLC·Filed 2022·Granted Jan 16, 2024·2 cites·13 claims
- 1488US12133912B2Stable pharmaceutical compositions of succinylcholine chlorideSLAYBACK PHARMA LLC·Filed 2023·Granted Nov 5, 2024·1 cites·1 claims
- 1587US12128089B2Stable liquid compositions of glucagonSLAYBACK PHARMA LLC·Filed 2023·Granted Oct 29, 2024·1 cites·20 claims
- 1686US12151020B2Ready-to-use injectable pharmaceutical compositions comprising neostigmine and glycopyrrolateSLAYBACK PHARMA LLC·Filed 2024·Granted Nov 26, 2024·0 cites·14 claims
- 1785US10702520B1Pharmaceutical compositions of posaconazoleSLAYBACK PHARMA LLC·Filed 2019·Granted Jul 7, 2020·2 cites·19 claims
- 1882US11938217B2Ready-to-use injectable pharmaceutical compositions comprising neostigmine and glycopyrrolateSLAYBACK PHARMA LLC·Filed 2023·Granted Mar 26, 2024·0 cites·19 claims
- 1982US11696906B2Stable oral suspensions of baclofenSLAYBACK PHARMA LLC·Filed 2022·Granted Jul 11, 2023·0 cites·8 claims
- 2082US2025032508A1Pharmaceutical compositions of testosteroneSLAYBACK PHARMA LLC·Filed 2024·Application pending·0 cites
- 2182US2026069570A1Stable pharmaceutical compositions of edaravoneSLAYBACK PHARMA LLC·Filed 2025·Application pending·0 cites
- 2280US12208086B2Stable pharmaceutical compositions of bendamustineSLAYBACK PHARMA LLC·Filed 2023·Granted Jan 28, 2025·0 cites·7 claims
- 2380US12138271B2Pharmaceutical compositions of testosteroneSLAYBACK PHARMA LLC·Filed 2023·Granted Nov 12, 2024·0 cites·16 claims
- 2480US11564898B1Stable oral suspensions of baclofenSLAYBACK PHARMA LLC·Filed 2022·Granted Jan 31, 2023·0 cites·10 claims
- 2579US12370190B2Stable liquid compositions of netupitant and palonosetronSLAYBACK PHARMA LLC·Filed 2024·Granted Jul 29, 2025·0 cites·18 claims
- 2679US12133854B2Pharmaceutical compositions of mifepristoneSLAYBACK PHARMA LLC·Filed 2023·Granted Nov 5, 2024·0 cites·12 claims
- 2779US11844784B2Stable pharmaceutical compositions of bendamustineSLAYBACK PHARMA LLC·Filed 2023·Granted Dec 19, 2023·0 cites·15 claims
- 2878US12343330B2Stable pharmaceutical compositions of edaravoneSLAYBACK PHARMA LLC·Filed 2023·Granted Jul 1, 2025·0 cites·27 claims
- 2978US11957685B2Pharmaceutical compositions of tofacitinib for oral administrationSLAYBACK PHARMA LLC·Filed 2023·Granted Apr 16, 2024·0 cites·24 claims
- 3077US2025221978A1Stable pharmaceutical compositions of apixabanSLAYBACK PHARMA LLC·Filed 2024·Application pending·0 cites
- 3177US2024131018A1Pharmaceutical compositions of cabozantinibSLAYBACK PHARMA LLC·Filed 2023·Application pending·0 cites
- 3277US2025057855A1Pharmaceutical compositions of mifepristoneSLAYBACK PHARMA LLC·Filed 2024·Application pending·0 cites
- 3376US12491178B2Stable pharmaceutical compositions of edaravoneSLAYBACK PHARMA LLC·Filed 2025·Granted Dec 9, 2025·0 cites·18 claims
- 3476US2024207278A1Pharmaceutical compositions of tofacitinib for oral administrationSLAYBACK PHARMA LLC·Filed 2024·Application pending·0 cites
- 3575US11642355B2Pharmaceutical compositions of testosteroneSLAYBACK PHARMA LLC·Filed 2022·Granted May 9, 2023·0 cites·15 claims
- 3674US12521383B2Stable pharmaceutical compositions of apixabanSLAYBACK PHARMA LLC·Filed 2025·Granted Jan 13, 2026·0 cites·17 claims
- 3774US12097197B2Stable liquid compositions of netupitant and palonosetronSLAYBACK PHARMA LLC·Filed 2022·Granted Sep 24, 2024·0 cites·24 claims
- 3874US2025082617A1Stable pharmaceutical compositions of apixabanSLAYBACK PHARMA LLC·Filed 2024·Application pending·0 cites
- 3974US2025049824A1Stable pharmaceutical compositions of cyclophosphamideSLAYBACK PHARMA LLC·Filed 2024·Application pending·0 cites
- 4072US2022387418A1Pharmaceutical compositions of cabozantinibSLAYBACK PHARMA LLC·Filed 2022·Application pending·0 cites
- 4172US2024180934A1Stable pharmaceutical compositions of cyclophosphamideSLAYBACK PHARMA LLC·Filed 2024·Application pending·0 cites
- 4272US2024122858A1Modified-release dosage forms of ruxolitinibSLAYBACK PHARMA LLC·Filed 2023·Application pending·0 cites
- 4371US12194028B2Stable pharmaceutical compositions of apixabanSLAYBACK PHARMA LLC·Filed 2023·Granted Jan 14, 2025·0 cites·16 claims
- 4471US11931370B2Stable pharmaceutical compositions of cyclophosphamideSLAYBACK PHARMA LLC·Filed 2022·Granted Mar 19, 2024·0 cites·4 claims
- 4571US11311554B2Pharmaceutical compositions of testosteroneSLAYBACK PHARMA LLC·Filed 2019·Granted Apr 26, 2022·0 cites·6 claims
- 4671US11110054B2Ready-to-use injectable pharmaceutical compositions comprising neostigmine and glycopyrrolateSLAYBACK PHARMA LLC·Filed 2018·Granted Sep 7, 2021·0 cites·10 claims
- 4771US10456354B1Ready-to-use injectable pharmaceutical compositions comprising neostigmine and glycopyrrolateSLAYBACK PHARMA LLC·Filed 2018·Granted Oct 29, 2019·0 cites·21 claims
- 4871US2025235431A1Stable pharmaceutical compositions of edaravoneSLAYBACK PHARMA LLC·Filed 2025·Application pending·0 cites
- 4971US2025032586A1Stable liquid compositions of glucagonSLAYBACK PHARMA LLC·Filed 2024·Application pending·0 cites
- 5070US2025248987A1Pharmaceutical compositions of cabozantinibSLAYBACK PHARMA LLC·Filed 2025·Application pending·0 cites
Showing the top 50 of 69 patent records by PatentIndex Score.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →